Onkologische Schwerpunktpraxis Dr. Anhut
- Address
- Friesener Str. 41, 96317 Kronach, Germany
Onkologische Schwerpunktpraxis Dr. Anhut - Hematologic Malignancies Research Center
Onkologische Schwerpunktpraxis Dr. Anhut is a specialized oncology practice with particular expertise in myeloproliferative neoplasms and hematologic disorders. The center is at the forefront of integrating advanced artificial intelligence methodologies into clinical research to improve treatment outcomes and patient stratification in rare blood cancers.
- Polycythemia vera treatment optimization and hydroxyurea resistance prediction
- Machine learning applications in hematologic malignancy management
- Prospective interventional studies in myeloproliferative disorders
The practice demonstrates innovation in utilizing artificial intelligence-derived predictive parameters to identify patients at risk for hydroxyurea resistance in polycythemia vera. This personalized approach to evaluating treatment intolerance patterns represents a significant advancement in managing this chronic myeloproliferative neoplasm, potentially enabling earlier therapeutic adjustments and improved long-term disease control.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Onkologische Schwerpunktpraxis Dr. Anhut
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| HU-F-AIM - A prospective, interventional study to evaluate HU-resistance in polycythemia vera patients who meet predictive parameters identified in the machine learning project PV-AIM | Novartis Pharma GmbH | Phase III | Not Recruiting | Jul 2023 | Feb 2026 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Hydroxycarbamide | 1 | Unknown | 2023-07-28 | 2023-07-28 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.